Hawthorne Gardening Company, the subsidiary of The Scotts Miracle-Gro Company (NYSE:SMG) that focuses on the ancillary agricultural technology side of the cannabis industry, has drawn a lot of attention from investors given its strategic partnerships and acquisitions in the booming cannabis industry.
Today's announcement from The Flowr Corporation is yet another example of how Hawthorne Gardening is quietly making moves to dominate the marijuana industry. Where as Hawthorne's prior participation in the industry remained firmly on the ancillary side of things, it looks like that's about to change.
Flowr is a vertically-integrated Canadian cannabis company with production facilities in Kelowna, BC and head office in Markham, ON. Flowr's status as a licensed producer under Health Canada's ACMPR allows the company to do things that Hawthorne could only dream of...until now.
Having received its production license back in December of 2017, Flowr is allowed to cultivate medical cannabis, and also perform research and development functions as outlined under their new agreement with Hawthorne Gardening.
The exclusive strategic R&D alliance between Flowr and Hawthorne Gardening brings together two world-leading organizations to construct and operate the first purpose-built research and development facility in North America dedicated exclusively to innovations in the cannabis industry.
Located next to Flowr's flagship cultivation facility in Kelowna, British Columbia, the new R&D facility will support scientists from both organizations. Areas of R&D will include nutrient formulations, lighting and environmental systems, irrigation, growing media, and integrated cultivation systems in support of Hawthorne's existing brands such as Botanicare, Gavita, General Hydroponics and Can-Filters. Researchers will also develop new strains and genetics for specific growing conditions and therapeutic purposes.
"We currently work with a broad range of licensed cannabis producers, but we have an especially deep respect for Flowr's facility construction and cultivation teams based on their unparalleled expertise and experience" said Chris Hagedorn, CEO of Hawthorne. "We look forward to collaborating with Flowr to spearhead a new era of innovation in the emerging cannabis industry."
The new 50,000 square foot R&D facility will combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. Construction will begin in second quarter 2018. The facility is expected to open in early 2019.
"Our alliance with Hawthorne gives us a unique opportunity to combine their deep expertise in cultivation products and systems with our industry-leading expertise in cannabis grow facility construction and cannabis cultivation techniques" said Tony Giorgi, CEO of Flowr. "We're excited about the advancements this alliance will bring to us, to Hawthorne, and to the cannabis industry."
Beyond the agreement with Hawthorne, Flowr is positioned extremely well for the upcoming recreational-use market in Canada with a line of premium cannabis products. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and Instagram!